DE69323303T2 - Zusammensetzungen zur Behandlung des trockenen Auges - Google Patents

Zusammensetzungen zur Behandlung des trockenen Auges

Info

Publication number
DE69323303T2
DE69323303T2 DE69323303T DE69323303T DE69323303T2 DE 69323303 T2 DE69323303 T2 DE 69323303T2 DE 69323303 T DE69323303 T DE 69323303T DE 69323303 T DE69323303 T DE 69323303T DE 69323303 T2 DE69323303 T2 DE 69323303T2
Authority
DE
Germany
Prior art keywords
dry eye
treatment compositions
eye treatment
compositions
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69323303T
Other languages
English (en)
Other versions
DE69323303D1 (de
Inventor
Donald Mackeen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deo Corp
Original Assignee
Deo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deo Corp filed Critical Deo Corp
Application granted granted Critical
Publication of DE69323303D1 publication Critical patent/DE69323303D1/de
Publication of DE69323303T2 publication Critical patent/DE69323303T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69323303T 1992-12-08 1993-12-07 Zusammensetzungen zur Behandlung des trockenen Auges Expired - Fee Related DE69323303T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/986,932 US5366739A (en) 1992-08-06 1992-12-08 Method of ophthalmic drug delivery
PCT/US1993/011873 WO1994013305A1 (en) 1992-12-08 1993-12-07 Method of ophthalmic drug delivery

Publications (2)

Publication Number Publication Date
DE69323303D1 DE69323303D1 (de) 1999-03-11
DE69323303T2 true DE69323303T2 (de) 1999-09-09

Family

ID=25532895

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69323303T Expired - Fee Related DE69323303T2 (de) 1992-12-08 1993-12-07 Zusammensetzungen zur Behandlung des trockenen Auges

Country Status (7)

Country Link
US (1) US5366739A (de)
EP (2) EP0630254B1 (de)
AU (1) AU677980B2 (de)
CA (1) CA2129635C (de)
DE (1) DE69323303T2 (de)
ES (1) ES2127375T3 (de)
WO (1) WO1994013305A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
CA2208268A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2732598B1 (fr) 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
CA2526362C (en) 2003-05-20 2012-10-09 James F. Collins Ophthalmic drug delivery system
US7678089B2 (en) * 2003-11-14 2010-03-16 Medical Instill Technologies, Inc. Delivery device and method of delivery
EP1720518B1 (de) * 2004-02-26 2009-08-12 Bausch & Lomb Incorporated Viskoelastische alginat-zusammensetzung, herstellungsverfahren und verpackung
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
WO2005113002A1 (ja) * 2004-05-21 2005-12-01 Senju Pharmaceutical Co., Ltd. ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
EP3372205A1 (de) 2007-09-07 2018-09-12 Mati Therapeutics Inc. Nachweis eines lakrimalen implantats
CN101842080A (zh) * 2007-11-01 2010-09-22 博士伦公司 非水的水混溶性物质作为药物递送的载体
CA2703000C (en) * 2007-11-05 2013-08-06 Bausch & Lomb Incorporated Water-immiscible materials as vehicles for drug delivery
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
US20100323978A1 (en) * 2009-06-22 2010-12-23 Calvin Hanna Non-aqueous oil delivery system for ophthalmic drugs
EA201390122A1 (ru) 2010-07-15 2014-05-30 Коринтиан Офтэлмик, Инк. Устройство для генерирования капель
EA201390120A3 (ru) 2010-07-15 2013-09-30 Коринтиан Офтэлмик, Инк. Доставка офтальмологических лекарственных средств
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
JP2013531548A (ja) 2010-07-15 2013-08-08 コリンシアン オフサルミック，インコーポレイティド 遠隔治療及び遠隔モニタリングを実施する方法及びシステム
CN104487028A (zh) 2011-12-12 2015-04-01 艾诺维亚股份有限公司 高模量聚合物喷射器机构、喷射器装置及其使用方法
CA3066408A1 (en) 2017-06-10 2018-12-13 Eyenovia, Inc. Methods and devices for handling a fluid and delivering the fluid to the eye

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070593A (en) * 1962-12-26 1967-06-01 Olin Mathieson Ophthalmic ointment composition and the preparation thereof
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
DE3851152T2 (de) * 1987-09-03 1995-01-26 Univ Georgia Res Found Cyclosporin-augenmittel.
BE1003578A4 (fr) * 1988-10-26 1992-04-28 Sandoz Sa Nouvelles compositions ophtalmiques a base d'une cyclosporine.
JP2827295B2 (ja) * 1989-07-04 1998-11-25 大正製薬株式会社 ビタミンａ類含有点眼剤
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤

Also Published As

Publication number Publication date
CA2129635C (en) 1999-04-27
US5366739A (en) 1994-11-22
CA2129635A1 (en) 1994-06-23
AU5686394A (en) 1994-07-04
WO1994013305A1 (en) 1994-06-23
EP0879601A2 (de) 1998-11-25
ES2127375T3 (es) 1999-04-16
AU677980B2 (en) 1997-05-15
EP0630254A1 (de) 1994-12-28
EP0630254A4 (de) 1997-01-15
EP0879601A3 (de) 2000-08-30
DE69323303D1 (de) 1999-03-11
EP0630254B1 (de) 1999-01-27

Similar Documents

Publication Publication Date Title
DE69323303D1 (de) Zusammensetzungen zur Behandlung des trockenen Auges
DE9320803U1 (de) Vorrichtung zur interstitiellen Behandlung
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DE69227883D1 (de) Riechstoffmikrokapseln zur Behandlung von Wäsche
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE69124293T2 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE69500089D1 (de) Behandlung von Geflügel
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69912972D1 (de) Antibiotische zusammensetzungen zur behandlung des auges
DE59712045D1 (de) Vorrichtung zur behandlung des herzens
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE69530860D1 (de) Behandlung der entzündung des sehnervs
BR9102126A (pt) Composicao de tratamento de tecido
DE69220051T2 (de) Vorrichtung zur Behandlung von Getreide
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69019345T2 (de) Zusammensetzung zur behandlung von samen.
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69215885D1 (de) Behandlung von fleisch
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE69614739D1 (de) Pflaster zur Behandlung von Pflanzen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69308762T2 (de) Behandlung des Muskulschwunds
DE69112743D1 (de) Anlage zur Behandlung von Tierexkrementen.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee